Insider · CIK 0001386932

Vetticaden Santosh

Reports to the SEC for 5 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001386932

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-02-06	Assertio Therapeutics, IncRestricted Stock UnitsA Award	SVP, Chief Medical Officer ***	AAward	+36.8K sh	—	—	36,800
2017-10-16	Assertio Therapeutics, IncStock OptionsA Award	SVP, Chief Medical Officer ***	AAward	+109K sh	—	—	109,343
2017-10-16	Assertio Therapeutics, IncRestricted Stock UnitsA Award	SVP, Chief Medical Officer ***	AAward	+53.3K sh	—	—	53,325
2017-02-21	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Interim CEO and CMO	AAward	+56K sh	—	—	56,000
2017-02-21	Insys Therapeutics, Inc.Restricted Stock UnitsA Award	Interim CEO and CMO	AAward	+14K sh	—	—	14,000
2017-01-12	Insys Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Interim CEO and CMO	AAward	+30K sh	—	—	30,000
2014-01-02	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer & SVP	AAward	+295K sh	—	—	295,100
2013-06-19	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer & SVP	AAward	+125K sh	—	—	125,000
2012-09-05	SVRASavara Inc · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer & SVP	AAward	+600K sh	—	—	600,000
2011-12-30	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+340 sh	$30.80	+$10.5K	8,773
2011-10-26	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+55K sh	$22.66	+$1.25M	63,433
2011-10-26	CUBIST PHARMACEUTICALS INCS Sale	SVP & Chief Medical Officer	SSale	−55K sh	$38.60	−$2.12M	8,433
2011-10-26	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−55K sh	—	—	25,000
2011-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+564 sh	$18.60	+$10.5K	8,346
2011-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+87 sh	$35.99	+$3,131.13	8,433
2011-05-15	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+2,237 sh	—	—	7,782
2011-05-15	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−2,237 sh	—	—	4,475
2011-05-14	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+1,875 sh	—	—	5,545
2011-05-14	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−1,875 sh	—	—	5,625
2011-05-13	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+45K sh	—	—	45,000
2011-05-13	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+7,200 sh	—	—	7,200
2011-03-31	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+312 sh	$25.24	+$7,874.88	3,670
2010-12-31	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+573 sh	$17.36	+$9,945.561	3,358
2010-10-15	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+40K sh	—	—	40,000
2010-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+173 sh	$20.60	+$3,563.8	2,785
2010-05-17	CUBIST PHARMACEUTICALS INCS Sale	SVP & Chief Medical Officer	SSale	−927 sh	$21.81	−$20.2K	2,612
2010-05-15	CUBIST PHARMACEUTICALS INCM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+2,237 sh	—	—	3,539
2010-05-15	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−2,237 sh	—	—	6,712
2010-05-14	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+7,500 sh	—	—	7,500
2010-05-14	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+35K sh	—	—	35,000
2010-03-31	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+331 sh	$22.54	+$7,460.74	1,302
2009-09-30	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+134 sh	$20.20	+$2,706.8	971
2009-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+356 sh	$15.58	+$5,546.658	610
2009-06-30	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+227 sh	$18.33	+$4,160.91	837
2009-05-15	CUBIST PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+8,949 sh	—	—	8,949
2009-03-31	CUBIST PHARMACEUTICALS INCJ Other	SVP & Chief Medical Officer	JOther	+254 sh	$16.36	+$4,155.44	254
2009-01-15	CUBIST PHARMACEUTICALS INCStock Options (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+80K sh	—	—	80,000
2008-02-01	MAXYGEN INCEmployee Stock Option (Right to Buy)A Award	Senior Vice President	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Feb 84
Vetticaden Santosh0001179110-18-001861
SEC(opens sec.gov)
Oct 184
Vetticaden Santosh0001179110-17-013378
SEC(opens sec.gov)
Feb 234
Insys Therapeutics, Inc.0001209191-17-014089
SEC(opens sec.gov)
Jan 174
Insys Therapeutics, Inc.0001209191-17-003809
SEC(opens sec.gov)
Jan 34
Mast Therapeutics, Inc.0001209191-14-001221
SEC(opens sec.gov)
Jun 214
Mast Therapeutics, Inc.0001209191-13-033244
SEC(opens sec.gov)
Sep 54
Vetticaden Santosh0001209191-12-044343
SEC(opens sec.gov)
Jan 44
Vetticaden Santosh0001127602-12-000544
SEC(opens sec.gov)
Oct 284
Vetticaden Santosh0001127602-11-027827
SEC(opens sec.gov)
Jul 54
Vetticaden Santosh0001127602-11-020527
SEC(opens sec.gov)
May 174
Vetticaden Santosh0001127602-11-016608
SEC(opens sec.gov)

Companies

Address

65 HAYDEN AVENUE

LEXINGTON, MA, 02421